Clinical Trial Update: A Study to Describe the Safety, Reactogenicity, and Immunogenicity of Herpes Zoster IN001 mRNA Vaccine (IN001) in Healthy Participants [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating the safety, reactogenicity, and immunogenicity of IN001, an mRNA vaccine for herpes zoster, in healthy participants. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Zoster

Drugs mentioned

• IN001

Snippet

Sponsor: Shenzhen Shenxin Biotechnology Co., Ltd | Conditions: Herpes Zoster | Phase 1 | Status: COMPLETED